Startup investment bank for the emerging markets JPIN Venture Catalysts (JPIN) has participated in a USD1.8 million investment round in BioSapien, a biotech that uses 3D Printed Biodegradable mesh designed to deliver cancer drugs directly to tumour sites with greater efficacy and reduced side effects.
Startup investment bank for the emerging markets JPIN Venture Catalysts (JPIN) has participated in a USD1.8 million investment round in BioSapien, a biotech that uses 3D Printed Biodegradable mesh designed to deliver cancer drugs directly to tumour sites with greater efficacy and reduced side effects.
Joining JPIN in the investment round is the global venture capital investor SOSV, as well as DC Capital Ventures, Hikma Ventures, Microventures, Side Door Ventures, Kartik Garg – The Modern Nomad, and other high net-work angels and investors. In addition to this funding, BioSapien has also received a USD256,000 grant from the National Science Foundation (NSF) to help accelerate the development of their patented product MediChip.
